共 19 条
[1]
ASO H, 1989, J BIOL RESP MODIF, V8, P180
[3]
Buege J A, 1978, Methods Enzymol, V52, P302
[4]
ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1987, 84 (21)
:7725-7729
[5]
ESTERBAUER H, 1987, J LIPID RES, V28, P495
[6]
CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN
[J].
FREE RADICAL RESEARCH COMMUNICATIONS,
1989, 6 (01)
:67-75
[8]
HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
[9]
2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells
[J].
EXPERIENTIA,
1996, 52 (02)
:159-166
[10]
COMPARATIVE-STUDY ON THE EFFECT OF LOW-DOSE VITAMIN-E AND PROBUCOL ON THE SUSCEPTIBILITY OF LDL TO OXIDATION AND THE PROGRESSION OF ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS
[J].
ARTERIOSCLEROSIS AND THROMBOSIS,
1994, 14 (08)
:1386-1391